Literature DB >> 15817823

Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analysing neuroprotective mechanisms.

Pablo Mendez1, Iñigo Azcoitia, Luis Miguel Garcia-Segura.   

Abstract

The actions of oestradiol in the brain involve interaction with growth factors, such as insulin-like growth factor-I (IGF-I). Many cells in the brain co-express receptors for oestradiol and IGF-I and both factors interact to regulate neural function. The relationship of oestrogen receptor alpha with IGF-I receptor through the mitogen-activated protein kinase and the phosphoinositide 3-kinase signalling pathways may represent the point of convergence used by these two factors to cooperatively modulate neuritic growth, synaptic plasticity, neuroendocrine events, reproductive behaviour and neuronal survival. In addition, Akt and glycogen synthase kinase 3beta are key molecular targets to explain the interaction of oestrogen and IGF-I receptor signalling in the promotion of neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817823     DOI: 10.1677/joe.1.06058

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  27 in total

Review 1.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

2.  17-Beta-estradiol-mediated activation of extracellular-signal regulated kinase, phosphatidylinositol 3-kinase/protein kinase B-Akt and N-methyl-D-aspartate receptor phosphorylation in cortical synaptoneurosomes.

Authors:  Reymundo Dominguez; Roulan Liu; Michel Baudry
Journal:  J Neurochem       Date:  2007-01-22       Impact factor: 5.372

3.  Bisphenol A Represses Dopaminergic Neuron Differentiation from Human Embryonic Stem Cells through Downregulating the Expression of Insulin-like Growth Factor 1.

Authors:  Boxian Huang; Song Ning; Qinjing Zhang; Aiqin Chen; Chunyan Jiang; Yugui Cui; Jian Hu; Hong Li; Guoping Fan; Lianju Qin; Jiayin Liu
Journal:  Mol Neurobiol       Date:  2016-06-07       Impact factor: 5.590

4.  Synthesis and biological activity of 3-N-substituted estrogen derivatives as breast cancer agents.

Authors:  Zhongliang Wan; Musiliyu A Musa; Patrick Joseph; John S Cooperwood
Journal:  Mini Rev Med Chem       Date:  2013-07       Impact factor: 3.862

5.  The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1.

Authors:  Amutha Selvamani; Farida Sohrabji
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

6.  Neonatal estradiol stimulation prevents epilepsy in Arx model of X-linked infantile spasms syndrome.

Authors:  Pedro R Olivetti; Atul Maheshwari; Jeffrey L Noebels
Journal:  Sci Transl Med       Date:  2014-01-22       Impact factor: 17.956

7.  Estrogen receptor-alpha overexpression suppresses 17beta-estradiol-mediated vascular endothelial growth factor expression and activation of survival kinases.

Authors:  Shameena Bake; Lijiang Ma; Farida Sohrabji
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

8.  Eccentric exercise activates novel transcriptional regulation of hypertrophic signaling pathways not affected by hormone changes.

Authors:  Lauren G MacNeil; Simon Melov; Alan E Hubbard; Steven K Baker; Mark A Tarnopolsky
Journal:  PLoS One       Date:  2010-05-18       Impact factor: 3.240

9.  Distribution and localization patterns of estrogen receptor-beta and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: localization of ERbeta and IGF-1R in substantia nigra.

Authors:  Arnulfo Quesada; Horacio E Romeo; Paul Micevych
Journal:  J Comp Neurol       Date:  2007-07-01       Impact factor: 3.215

10.  Signaling mechanisms involved in the acute effects of estradiol on 5-HT clearance.

Authors:  Saloua Benmansour; Anthony A Privratsky; Opeyemi S Adeniji; Alan Frazer
Journal:  Int J Neuropsychopharmacol       Date:  2014-01-15       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.